Sentiss Pharma Pvt Executive and Leadership Team

Deepak Bahri, the Founder & Chief Executive Officer at Sentiss Pharma Pvt, directs the overarching strategic vision for the organization. This leadership role involves guiding the development of specialized ophthalmic, inhalation, and otic product lines to ensure global market competitiveness. By aligning research initiatives with patient health outcomes, the Founder & Chief Executive Officer drives the company toward long-term growth and innovation. Deepak Bahri maintains constant oversight of international expansion efforts, ensuring that the pharmaceutical portfolio meets stringent quality benchmarks across diverse regulatory environments. Through collaboration with the board and senior management, the Founder & Chief Executive Officer secures the necessary resources to scale manufacturing capabilities. This executive leadership ensures that the company remains a leader in niche pharmaceutical segments while upholding the core mission of delivering accessible, high-quality healthcare solutions to patients worldwide.

Debajit Sensharma, the Chief Financial Officer at Sentiss Pharma Pvt, manages the fiscal health and capital allocation strategies for the entire enterprise. Overseeing global financial planning and analysis, the Chief Financial Officer ensures that the company maintains the liquidity required to support complex pharmaceutical manufacturing operations. Debajit Sensharma directs the budgeting processes that fuel research and development for ophthalmic and nasal drop products. By monitoring market trends and economic shifts, the Chief Financial Officer mitigates financial risks associated with international trade and supply chain logistics. This leadership role involves providing the board with accurate financial reporting to facilitate informed decision-making regarding future investments. Through rigorous cost management and revenue optimization, the Chief Financial Officer strengthens the balance sheet, enabling the company to sustain its commitment to quality and social responsibility while achieving consistent profitability in the competitive pharmaceutical sector.

Joyeeta Chatterjee, the Chief Human Resources Officer at Sentiss Pharma Pvt, architects the organizational culture and talent acquisition strategies that sustain the company's status as a top workplace. Overseeing employee engagement and professional development, the Chief Human Resources Officer ensures that the workforce remains aligned with the mission of delivering innovative healthcare solutions. Joyeeta Chatterjee directs initiatives that promote community engagement and internal satisfaction, which directly contribute to the company's recognition as a Great Place to Work. This leadership role involves designing performance management systems that reward excellence in manufacturing and research functions. By fostering an inclusive environment, the Chief Human Resources Officer supports the retention of top-tier talent necessary for maintaining high quality standards. Through strategic workforce planning, the Chief Human Resources Officer ensures that the organization possesses the human capital required to scale operations and meet the evolving demands of the global pharmaceutical market.

Sooraj Oswal, the Cfa at Sentiss Pharma Pvt, evaluates investment opportunities and financial performance metrics to support the company's long-term growth objectives. Analyzing the profitability of the ophthalmic and inhalation product portfolios, the Cfa provides critical insights that guide capital expenditure decisions. Sooraj Oswal directs the assessment of market-specific financial risks, ensuring that the company maintains a robust position within the global pharmaceutical landscape. This leadership role involves collaborating with the finance department to optimize asset utilization and improve operational efficiency across manufacturing facilities. By conducting detailed financial modeling, the Cfa assists the executive team in identifying new avenues for revenue generation and market penetration. Through the application of rigorous analytical standards, the Cfa ensures that all strategic initiatives align with the company's commitment to fiscal responsibility and sustainable development, ultimately supporting the delivery of high-quality healthcare solutions to patients across various international regions.